Prof. Diana Gorog, Consultant Cardiologist

Prof. Diana Gorog

Consultant Cardiologist

Book online
|

Prof. Diana Gorog MB, MS, FRCP, MD, PhD, FESC

Consultant Cardiologist

MB, MS, FRCP, MD, PhD, FESC

Prof. Diana Gorog

Consultant Cardiologist MB, MS, FRCP, MD, PhD, FESC

Book online
|
MB, MS, FRCP, MD, PhD, FESC
HCA-Healthcare-UK

Areas of expertise

  • Acute coronary syndrome (ACS)
  • Angina
  • Arrhythmia (irregular heartbeat)
  • Atherosclerosis
  • Atrial fibrillation
HCA-Healthcare-UK

Recommendations for Prof. Gorog

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Address

About Prof. Diana Gorog

GMC number: 4034982

Year qualified: 1993

Place of primary qualification: University of London

Prof. Diana Gorog is a highly esteemed Consultant Cardiologist based at The Harley Street Clinic in London. She also holds prestigious academic positions as a Professor at the University of Hertfordshire and a Visiting Professor at Imperial College London.

Prof. Gorog's medical journey began in 1993 when she qualified from St Bartholomew's Medical School, London. She subsequently completed her specialist cardiology training at several renowned hospitals across London. Her areas of specialisation include General and Interventional Cardiology, with a particular focus on patients suffering from coronary heart disease. She is adept at managing conditions such as angina, hypertension, heart failure, and irregular heartbeats.

In her clinical practice, Prof. Gorog performs a variety of advanced procedures, including coronary angiography, angioplasty, and other interventional techniques. She is proficient in conducting essential medical tests such as 24-hour ECG monitoring, CT Coronary Angiograms, and standard ECGs (electrocardiograms).

Prof. Gorog treats a wide range of conditions, including Acute Coronary Syndrome, Coronary Artery Disease, chest pain, palpitations, pulmonary hypertension, angina, valvular heart disease, arrhythmia (irregular heartbeat), and congestive heart failure.

Beyond her clinical duties, Prof. Gorog is deeply involved in cardiology research, with a specific interest in thrombosis and the prevention of heart attacks. Her research contributions aim to advance the understanding and treatment of cardiovascular diseases, ultimately improving patient outcomes.

Since her appointment, Prof. Gorog has been dedicated to providing exceptional care to her patients while also contributing to the academic and research communities in cardiology. Her commitment to both clinical excellence and innovative research makes her a leading figure in her field.

Areas of expertise

  • Cardiology
  • Arrhythmia
  • Atrial fibrillation
  • Coronary artery disease
  • Echocardiography
  • Hypertension
  • Interventional cardiology
  • Vascular medicine

Professional memberships

Royal College of Physicians
British Medical Association (BMA)
British Cardiovascular Society
British Cardiac Interventional Society
European Society of Cardiology
General Medical Council

Articles by Prof. Diana Gorog

Non-vitamin k antagonist oral anticoagulants versus warfarin for patients with left ventricular thrombus: a systematic review and meta-analysis

Role, laboratory assessment and clinical relevance of fibrin, factor xiii and endogenous fibrinolysis in arterial and venous thrombosis

Prevalence of thrombotic complications in icu-treated patients with coronavirus disease 2019 detected with systematic ct scanning

Ethnic difference of thrombogenicity in patients with cardiovascular disease: a pandora box to explain prognostic differences

Thrombotic complications in 2,928 patients with covid-19 treated in intensive care: a systematic review

Assessment of endogenous fibrinolysis in clinical using novel tests - ready for clinical roll-out?

Out-of-hospital cardiac arrest: a systematic review of current risk scores to predict survival

Endogenous fibrinolysis - relevance to clinical thrombosis risk assessment

Antithrombotic therapy in diabetes: which, when 1 and for how long?

Precision treatment in acs – role of assessing fibrinolysis